Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14


Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.

Soderstrom K, Soliman E, Van Dross R.

Front Pharmacol. 2017 Oct 10;8:720. doi: 10.3389/fphar.2017.00720. eCollection 2017. Review.


Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders.

Roche M, Finn DP.

Pharmaceuticals (Basel). 2010 Aug 10;3(8):2517-2553. Review.


Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.

Scholl A, Ivanov I, Hinz B.

Oncotarget. 2016 Sep 20;7(38):61438-61457. doi: 10.18632/oncotarget.11367.


Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway.

Walther U, Emmrich K, Ramer R, Mittag N, Hinz B.

Oncotarget. 2016 Mar 1;7(9):10345-62. doi: 10.18632/oncotarget.7213.


Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and P-Selectin Activity.

Esain V, Kwan W, Carroll KJ, Cortes M, Liu SY, Frechette GM, Sheward LM, Nissim S, Goessling W, North TE.

Stem Cells. 2015 Aug;33(8):2596-612. doi: 10.1002/stem.2044. Epub 2015 May 26.


The Endocannabinoid System in the Postimplantation Period: A Role during Decidualization and Placentation.

Fonseca BM, Correia-da-Silva G, Almada M, Costa MA, Teixeira NA.

Int J Endocrinol. 2013;2013:510540. doi: 10.1155/2013/510540. Epub 2013 Oct 21. Review.


Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.

Ramer R, Walther U, Borchert P, Laufer S, Linnebacher M, Hinz B.

J Lipid Res. 2013 Nov;54(11):3116-29. doi: 10.1194/jlr.M042283. Epub 2013 Aug 12.


Cannabinoids, endocannabinoids, and cancer.

Hermanson DJ, Marnett LJ.

Cancer Metastasis Rev. 2011 Dec;30(3-4):599-612. doi: 10.1007/s10555-011-9318-8. Review.


Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade.

Kuc C, Jenkins A, Van Dross RT.

Mol Carcinog. 2012 Feb;51(2):139-49. doi: 10.1002/mc.20770. Epub 2011 Mar 22.


Celecoxib antagonizes perifosine's anticancer activity involving a cyclooxygenase-2-dependent mechanism.

Elrod HA, Yue P, Khuri FR, Sun SY.

Mol Cancer Ther. 2009 Sep;8(9):2575-85. doi: 10.1158/1535-7163.MCT-09-0390. Epub 2009 Sep 15.


Changes in the endocannabinoid system may give insight into new and effective treatments for cancer.

Alpini G, Demorrow S.

Vitam Horm. 2009;81:469-85. doi: 10.1016/S0083-6729(09)81018-2. Review.


PPARgamma and Apoptosis in Cancer.

Elrod HA, Sun SY.

PPAR Res. 2008;2008:704165. doi: 10.1155/2008/704165.


The endocannabinoid system as an emerging target of pharmacotherapy.

Pacher P, Bátkai S, Kunos G.

Pharmacol Rev. 2006 Sep;58(3):389-462. Review.


The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2.

Patsos HA, Hicks DJ, Dobson RR, Greenhough A, Woodman N, Lane JD, Williams AC, Paraskeva C.

Gut. 2005 Dec;54(12):1741-50. Epub 2005 Aug 11.

Supplemental Content

Support Center